Prognostic marker for diagnosis of pleomorphic solid pseudopapillary neoplasm of the pancreas and selecting method for loading an anticancer drug on patch

摘要

The present invention relates to a novel biomarker for distinguishing and diagnosing pancreatic cancer, in particular, a pneumomediastinum (pleomorphic solid pseudopapillary neoplasm, pleomorphic SPN), and a use thereof, and more particularly, Use of the p53 gene as a diagnostic marker of a polymorphic solid pleuropneumonuclear tumor of the pancreas using mutation characteristics and the use of the p53 gene as a diagnostic marker for the selection and / or administration of an anticancer drug to prevent recurrence or metastasis after pancreatic cancer surgery And a method for providing information for decision.